Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT01708161
Title A Phase Ib/II Study of the Combination of BYL719 Plus AMG 479 in Adult Patients With Selected Solid Tumors
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Novartis|Novartis Pharmaceuticals|Amgen
Age Groups: adult
Covered Countries USA | ESP | CAN | BEL

Additional content available in CKB BOOST